针对MMP的纳米药物输送系统:对结质瘤的有希望的治疗方法
Jie Liu1,2, Pengfei Xie2, Zhicheng Wang2
1Department of Radiotherapy, Second Hospital of Jilin University, Changchun, Jilin, People's Republic of China.
International journal of nanomedicine
|December 12, 2025
概括
矩阵金属蛋白酶 (MMPs) 是质瘤进展的关键. 通过细胞透 (CPPs) 激活的MMP响应纳米药物递送系统,为像质母细胞瘤这样的大脑瘤提供了向治疗.
科学领域:
- 神经瘤学神经瘤学
- 生物技术是生物技术.
- 纳米医学是一种纳米医学.
背景情况:
- 质瘤,特别是质母细胞瘤 (IV级),是中枢神经系统 (CNS) 的侵袭性瘤,预后不佳.
- 矩阵金属蛋白酶 (MMPs) 在瘤微环境中发挥着关键作用,影响质瘤恶性,入侵和转移.
- 纳米粒子药物递送系统在各种病理中提供了针对性和持续性药物递送的潜力.
研究的目的:
- 审查MMP和质瘤之间的关系,包括监管机制.
- 讨论纳米药物输送系统,纳米材料和用于质瘤治疗的输送途径.
- 探索细胞透 (CPPs) 在MMP响应性纳米药物输送系统中的应用.
主要方法:
- 关于MMP,质瘤和纳米药物输送系统的综合文献综述.
- 在质瘤组织中MMP表达的分析和与恶性瘤的相关性.
- 专注于可激活的CPP及其集成到MMP响应纳米系统中.
主要成果:
- MMP表达与质瘤等级和攻击性有积极的相关性,这表明它们作为治疗点的潜力.
- 响应MMP的纳米药物输送系统可以激活CPP,从而实现有针对性的药物释放.
- 这些系统展示了高效的血脑屏障 (BBB) 透和质瘤向.
结论:
- 瘤瘤是瘤检测和治疗的可行的目标.
- 响应MMP的纳米药物输送系统与CPP相结合,为质瘤管理提供了一个有希望的策略.
- 这种方法提高了药物输送效率和精度,可能有利于质瘤患者.
更多相关视频
07:25Author Spotlight: Multimodal Imaging Strategies for Optimizing Drug Delivery and Early Detection in Glioblastoma Treatment
Published on: March 1, 2024
2.9K
09:02Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment
Published on: September 27, 2024
3.0K
相关概念视频
01:24Modified-Release Drug Delivery Systems: Site-Targeted
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
01:24Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...